It was developed immediately after Ozempic (semaglutide), which was approved to assist lower blood sugar in people with kind two diabetic issues in 2017, and found to bring about weight reduction. Novo Nordisk formulated Wegovy, which is similar to, but not interchangeable, with Ozempic to tap into the weight reduction current market. Like most is